Physician profile
Troy Edwin Hampton
NPI 1275536377
$7,699.34
in general payments reported to CMS, 2019-2025
45 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $524 · 2021: $662 · 2022: $1,420 · 2023: $1,723 · 2024: $1,103 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,804 · Education: $65.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,803.75 |
| Education | $65.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,176.19 | 2021-2025 | |
| Novo Nordisk INC | $758.01 | 2019-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $544.81 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $451.09 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $374.70 | 2022-2025 | |
| Grifols USA, LLC | $361.98 | 2019-2025 | Prolastin-C Liquid |
| Pfizer INC. | $358.19 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $279.93 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $267.36 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $245.61 | 2019-2023 | |
| Dexcom, INC. | $219.75 | 2022-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $213.73 | 2019-2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Astrazeneca Pharmaceuticals LP | $188.28 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbott Laboratories | $186.71 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $185.55 | 2022-2023 | Otezla, Repatha, Evenity |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.